[Brief Summary] Commemorating the Renewal of NCD Alliance Japan “Improving Healthcare Environments Together with People Living with or Affected by NCDs ~ Driving Social Change through Lived Experience Engagement ~” (November 13, 2019)
date : 11/22/2019
The NCD Alliance Japan held a global forum commemorating the renewal of NCD Alliance Japan under the title “Improving Healthcare Environments Together with People Living with or Affected by NCDs (Non-communicable Diseases) ~ Driving Social Change through Lived Experience Engagement ~” on 13 November 13, 2019, at Gakushikaikan in Tokyo.
The NCD Alliance is a network of over 2,000 organizations in more than 170 countries and now includes 65 national/regional NCD alliances like NCD Alliance Japan. The NCD Alliance Japan, which is facilitated by HGPI, is being renewed at this point to further promote comprehensive, cross-cutting NCD measures in several areas, aiming to be a bridging body to provide a cross-disease collaboration platform for promoting policy recommendation activities, supporting empowerment of patients and family members, and conducting qualitative and quantitative research to spread expertise outside Japan.
■Keynote Speeches
Ms. Hiroko Nishimoto, Manager of HGPI and the Secretariat of NCD Alliance Japan, gave an introductory speech on the activities and vision for NCD Alliance Japan, in which she outlined the NCD policy landscape in Japan, noting that some progress has been seen in patient participation in policy development, such as in the area of oncology where the Cancer Control Act was established in 2006, which was the first case of reflecting patient voices into policy. She emphasized the need for civil society to come together and raise their voices in response to the fact that Japan lags behind other countries in regulating tobacco, alcohol, saturated and trans fat. Ms. Nishimoto stated that the major advocacy priorities of NCD Alliance Japan are improving overall health literacy, establishing an optimum healthcare system and encouraging employment and social participation for people living with NCDs. Ms. Nishimoto stated that the renewed NCD Alliance Japan would do its utmost to support these activities.
Mr. Takeshi Shukunobe, President and CEO of PPeCC (Power to the People with Chronic Conditions), delivered a keynote address entitled “Envisioning the Improvement of Healthcare Environments Together with People Living with or Affected by NCDs”. Mr. Shukunobe addressed the significance and importance of cross-disease efforts as “it resolves issues quickly and efficiently when people share knowledge with each other.” He also stressed the significance of “collaborative health care with patients” which is preferred rather than “patient-centered health care” in which people in all positions and occupations involved in medical care share a mutual goal and move forward together toward those goals.
Ms. Katie Dain, Chief Executive Officer of the NCD Alliance, gave a special address entitled “The Global Response to NCDs and the Meaningful Involvement of People Living with NCDs at All Levels and All Sectors” in which she highlighted that NCDs are the leading cause of death in virtually every region, and that in addition to the five modifiable risk factors for NCDs – tobacco use, harmful use of alcohol, unhealthy diet, physical inactivity, and air pollution – a lack of global funding and resources allocated compared to the level of disease burden is also a common driver. Although tremendous progress has been made on bring greater attention NCDs at the international level, including their inclusion in the Sustainable Development Goals (SDGs), and the launch of the World Health Organization (WHO) Global Action Plan on NCDs and a set of ‘best buys’ for NCDs that are known to be effective on health outcomes and provide return on investment, she highlighted concerns on progress, including a projection that half of all countries are on track to miss the targets set out in SDG3.4, and interference from big food and big alcohol employing the same tactics used by big tobacco in the past. To address these issues, strong policy leadership is required at the national and regional level, reflecting the voice of those living with NCDs, as well as the importance of civil society to play a watchdog role.
■Panel Discussion
At this Global Forum, two-panel discussions were held. During the first panel entitled “Driving Social Change with My Story ~Trends and Challenges in the Improvement of Health Environments~”, representatives of several patient support organizations shared personal stories of lived experience as well as NCD cross-cutting issues. During the second panel discussion entitled “Driving Social Change by Uniting Multi-stakeholders ~Trends and Challenges in the Promotion of Patient Engagement”, panelists shared best practices for patient engagement and coalition building from both inside and outside Japan and addressed how best to proceed with various stakeholders in the policy-making/dissemination arena.
In recent years of policy planning and implementation in Japan, measures that emphasize reflecting the voices of the people living with and affected by NCDs have been born, but have not yet spread widely into the Japanese society. The need for legislation to ensure patient involvement in the policy-making process affecting health care was readdressed.
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)